Electroconvulsive Therapy After Maxillofacial Metallic Implants
Freeman, G. Mark MD, PhD; Perry, Matthew T. MD; Manatt, George S. MD; Cristancho, Pilar MD
Accumulating evidence suggests that electroconvulsive therapy (ECT) can be both safe and effective in the setting of intracranial or craniofacial metallic implants.1–6 We present a case where ECT was successfully used to treat a 49-year-old woman with major depressive disorder resistant to medication management.
The Role of ECT in Suicide Preventio
Fink, Max MD*; Kellner, Charles H. MD†; McCall, W. Vaughn MD‡
For ECT, a comparison of the frequency of suicides in different decades found decreased rates when ECT was the dominant treatment for mental illness.23
Practical Considerations in the Use of Ultrabrief ECT in Clinical Practice
Galletly, Cherrie MBChB, DPM, FRANZCP, PhD*†‡; Clarke, Patrick BMBS, FRANZCP*†; Paterson, Tom MBBS, Dip Clin Hyp, FRANZCP*†; Rigby, Ashlee BPsych (Hons)*†; Gill, Shane BMBS, FRANZCP, Dip Psychotherapy*†
Although recognizing the advantages of UB ECT, we were concerned about the impact of introducing UB ECT on the demand for ECT services and length of inpatient stay.7
Comparing Effects of Ketamine and Thiopental Administration During Electroconvulsive Therapy in Patients With Major Depressive Disorder: A Randomized, Double-Blind Study
Yoosefi, Abolghasem MD*; Sepehri, Amir Sasan PharmD†; Kargar, Mona PharmD‡; Akhondzadeh, Shahin PhD§; Sadeghi, Majid MD∥; Rafei, Ali MSc¶; Alimadadi, Abbas MS#; Ghaeli, Padideh PharmD**
Despite of the high efficacy of ECT as a treatment option in many psychiatric disorders, one of the remarkable drawbacks to its use is cognitive dysfunction.9Recently, anesthetic drugs in ECT have been considered not only as anesthesia-inducing agents but also as active agents that may impact the cognitive outcome of the procedure.10
Does Comorbid Alcohol and Substance Abuse Affect Electroconvulsive Therapy Outcome in the Treatment of Mood Disorders?
Moss, Lori MD*†; Vaidya, Nutan MD*†
One of the factors associated with poor antidepressant medication response is alcohol and substance abuse.3 The comorbidity of depressive disorder and substance abuse is common.
Are Reports of Cognitive Testing Among Older Electroconvulsive Therapy Recipients Clinically Valid?
Plakiotis, Chris MBBS, MPM, MCR, FRANZCP*; Chin, Loi Fei MBBS, MPM†; O’Connor, Daniel W. MD, FRANZCP
Recent reviews suggest that correctly dosed right unilateral and bitemporal ECT is associated with few if any long-term cognitive adverse effects in older people.
Does Rocuronium-Sugammadex Reduce Myalgia and Headache After Electroconvulsive Therapy in Patients With Major Depression?
Saricicek, Vahap MD*; Sahin, Levent MD*; Bulbul, Feridun MD†; Ucar, Sevgi MD*; Sahin, Mehrican MD‡
Succinylcholine remains as one of the most commonly used muscle relaxants for short and daily procedures including electroconvulsive therapy (ECT), because of the rapid onset and short duration of action, although it has many adverse effects.1
Preanesthesia Medical Evaluation for Electroconvulsive Therapy: A Review of the Literature
Sundsted, Karna K. MD*; Burton, Mary Caroline MD*; Shah, Riddhi MBBS*; Lapid, Maria I. MD†
It has been established that ECT is a safe and effective procedure even in geriatric or medically complicated patients and is initiated and performed in both the inpatient and outpatient settings.1,2
Sociodemographic Characterization of ECT Utilization in Hawaii
Ona, Celia M. MD*†; Onoye, Jane M. PhD†‡; Goebert, Deborah DrPH†‡; Hishinuma, Earl PhD†; Bumanglag, R. Janine BS†; Takeshita, Junji MD†‡; Carlton, Barry MD†‡; Fukuda, Michael MSW†
Major depression remains common in psychiatric settings, affecting 18 million US residents and 340 million worldwide.1,2 Two thirds of all suicides are related to depression, and approximately 15% of individuals diagnosed with major depression die by suicide.3,4